Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Fuji
Federal Trade Commission
Moodys
Johnson and Johnson
Teva
Queensland Health
Express Scripts

Generated: June 25, 2018

DrugPatentWatch Database Preview

Urofollitropin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for urofollitropin and what is the scope of urofollitropin freedom to operate?

Urofollitropin
is the generic ingredient in three branded drugs marketed by Serono and Ferring, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for urofollitropin. One supplier is listed for this compound.
Synonyms for urofollitropin
(4-Threonine)oxytocin
1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxope
1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv.
146479-72-3
26995-91-5
27115-19-1
4-(L-Threonine)oxytocin
97048-13-0
AC1L1XUA
AM000363
Bravelle
Bravelle (TN)
C42H65N11O12S2
CHEMBL3249216
CHEMBL3276116
D02SBQ
Fertinex
Fertinex (TN)
Fertinorm HP
Follistim
Follistim (TN)
Gonal-F(TN)
Metrodin
Oxytocin, 4-L-threonine-
R541
SCHEMBL19712185
Urofollitrophin
ZINC169318398

US Patents and Regulatory Information for urofollitropin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Serono METRODIN urofollitropin INJECTABLE;INTRAMUSCULAR 019415-003 Sep 18, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-004 Aug 23, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring BRAVELLE urofollitropin INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 021289-001 May 6, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for urofollitropin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-004 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Farmers Insurance
AstraZeneca
Fuji
Express Scripts
Teva
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.